While phosphorylation by various kinases has been demonstrated to stabilize SOX2 in multiple cancers, it remains unclear whether the aberrant overexpression of SOX2 in osteosarcoma (OS) is partially attributable to enhanced stability through phosphorylation. Here, SOX2 is linked to cancer.